Medical News

RSS

Medicare Advantage premiums jump 14 percent

The Associated Press: "Millions of seniors who signed up for popular private health plans through Medicare are facing sharp premium increases this year — another sign that spiraling costs are a problem even for those with solid insurance. A study to be released Friday ... found that premiums for Medicare Advantage plans offering medical and prescription drug coverage jumped 14.2 percent on average in 2010, after an increase of only 5.2 percent the previous year. Some 8.5 million elderly and disabled Americans are in the plans, which provide more comprehensive coverage than traditional Medicare."

19 Feb 2010

Unveil Your Pink: Excitement surrounds upcoming charity fundraiser

As March 20th grows near, excitement surrounding the upcoming charity fundraiser, "Unveil Your Pink", mounts. "Unveil Your Pink" is being organized by South Florida-based women's networking organization, Women On The Move, founded by Leslie Harris. The Charity Event, that benefits The South Florida Affiliate of Susan G. Komen For The Cure, features Real Housewife Of Atlanta, Lisa Wu Hartwell and DJ Cassidy.

19 Feb 2010

Nutrient-rich California avocados hit grocery stores

California avocado season has arrived, making this delectable fruit readily available at grocery stores throughout the country. March through September marks the California avocado season, so now is the perfect time to incorporate this premium fruit in avocado-centric recipes created by chefs Mary Sue Milliken and Susan Feniger.

19 Feb 2010

Conference for Young Women Affected by Breast Cancer: 10th anniversary

2010 marks the 10th anniversary of the only international conference dedicated to the critical issues of young breast cancer survivors and those who care about them. Nearly 1,000 young breast cancer survivors, caregivers and medical professionals from around the world are expected to attend the 10th Annual Conference for Young Women Affected by Breast Cancer, to be held Friday, Feb. 26-Sunday, Feb. 28 at the Sheraton Atlanta Hotel in Atlanta, Ga.

19 Feb 2010

BioCrossroads' Indiana Seed Fund invests $400,000 in Bioscience Vaccines

BioCrossroads' Indiana Seed Fund has invested in Bioscience Vaccines, Inc. to accelerate the development of biologic materials, which may boost the effectiveness of a wide range of life-saving vaccines.

19 Feb 2010

Universal Detection Technology to commence marketing of passive zone security sensor

Universal Detection Technology, a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, reported today test results for its passive zone security sensor, developed through its partnership with Precision Sensors Instrumentation (PSI), a leading developer of security sensors.

19 Feb 2010

Kinesin protein motor shuttles cargo within cells and helps cells divide by rocking like a seesaw

Life's smallest motor, a protein that shuttles cargo within cells and helps cells divide, does so by rocking up and down like a seesaw, according to research conducted by scientists at the U.S. Department of Energy's Lawrence Berkeley National Laboratory and Brandeis University.

19 Feb 2010

Scientists develop new way to make simple oil droplets smart enough to navigate through complex maze

Call them oil droplets with a brain or even "chemo-rats." Scientists in Illinois have developed a way to make simple oil droplets "smart" enough to navigate through a complex maze almost like a trained lab rat. The finding could have a wide range of practical implications, including helping cancer drugs to reach their target and controlling the movement of futuristic nano-machines, the scientists say.

19 Feb 2010

GenVec announces new contract with DHS to develop adenovector-based vaccines against FMD

Today GenVec, Inc. announced a new contract with the Department of Homeland Security to continue the development of adenovector-based vaccines against foot-and-mouth disease (FMD) based on research and development done in collaboration with USDA-ARS and DHS S&T scientists at the Plum Island Animal Disease Center.

19 Feb 2010

HMS reports financial results for fourth-quarter and full-year ended December 31, 2009

HMS today announced financial results for its fourth quarter and full year ended December 31, 2009.

19 Feb 2010

Neovasc completes final tranche of previously announced non-brokered private placement

Neovasc Inc. today announced that it has completed the final tranche of a previously announced non-brokered private placement. The aggregate gross proceeds of the financing totaled $1.537 million through placement of approximately 5.692 million units at a price of $0.27 per unit, comprised of a first tranche of $1.329 million announced January 28, 2010 and this second tranche of $208,000.

19 Feb 2010

Petzel takes oath to lead nation's largest integrated health care system

Dr. Robert A. Petzel has taken the oath of office as the Under Secretary for Health within the Department of Veterans Affairs (VA), stepping up to lead the nation's largest integrated health care system.

19 Feb 2010

New book explores economic, demographic and cultural aspects that threaten healthcare and AMCs

Arthur Feldman, M.D., Ph.D, Magee Professor and Chairman, Department of Medicine at Jefferson Medical College, has written a new book, Pursuing Excellence In Healthcare: Preserving America's Academic Medical Centers, one of the first textbooks since the works of Abraham Flexnor in 1910 to take a comprehensive look at the issues facing academic medicine.

19 Feb 2010

Variations among individual organisms attributed to differences in genes, environment or chance

Biologists attribute variations among individual organisms to differences in genes or environment, or both. But a new study of nematode worms with identical genes, raised in identical environments, has revealed another factor: chance.

19 Feb 2010

Traditional gauges of economic activity overstate standard of living, say researchers

Traditional gauges of economic activity severely overstate the standard of living as experienced on 'Main Street,' say University of Maryland researchers, who have worked with their state officials to apply a more accurate and greener index.

19 Feb 2010

Rib-X Pharmaceuticals co-founder discovers new ribosomal structures of antibiotics

Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, and Yale University today announced the discovery by Thomas Steitz, Ph.D., co-founder of Rib-X and Yale University professor, of important new ribosomal structures of antibiotics, enabling the potential creation of novel treatments for drug resistant infections, including resistant tuberculosis (TB).

19 Feb 2010

MDS intends to make Substantial Issuer Bid

MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that the Company intends to make a Substantial Issuer Bid (the "offer"), pursuant to which the Company will offer to repurchase for cancellation up to between 40% and 46% of its outstanding Common Shares for an aggregate purchase price of up to US$450 million.

19 Feb 2010

LifePoint Hospitals reports fourth-quarter and full-year 2009 financial results

LifePoint Hospitals, Inc. today announced results for the fourth quarter and year ended December 31, 2009.

19 Feb 2010

University of Missouri researchers visualize "terminals" inside proline degrading enzyme

If subway terminals didn't exist and people had to exit subway stations to switch subway lines, transit time would increase. People also may encounter distractions, such as grabbing a cup of coffee, instead of getting on the other line. Molecules also use "terminals" to save transit time during enzyme-catalyzed processes. Using advanced X-radiation techniques, University of Missouri researchers were able to visualize one of these terminals inside of an enzyme that degrades proline, which is an amino acid that has a central role in metabolism.

19 Feb 2010

Nuvo Research reports net income in fourth-quarter, driven by FDA approval of Pennsaid

Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered into and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced its financial and operational results for the year and the fourth quarter ended December 31, 2009.

19 Feb 2010

Medical News

Medicare Advantage premiums jump 14 percent

Unveil Your Pink: Excitement surrounds upcoming charity fundraiser

Nutrient-rich California avocados hit grocery stores

Conference for Young Women Affected by Breast Cancer: 10th anniversary

BioCrossroads' Indiana Seed Fund invests $400,000 in Bioscience Vaccines

Universal Detection Technology to commence marketing of passive zone security sensor

Kinesin protein motor shuttles cargo within cells and helps cells divide by rocking like a seesaw

Scientists develop new way to make simple oil droplets smart enough to navigate through complex maze

GenVec announces new contract with DHS to develop adenovector-based vaccines against FMD

HMS reports financial results for fourth-quarter and full-year ended December 31, 2009

Neovasc completes final tranche of previously announced non-brokered private placement

Petzel takes oath to lead nation's largest integrated health care system

New book explores economic, demographic and cultural aspects that threaten healthcare and AMCs

Variations among individual organisms attributed to differences in genes, environment or chance

Traditional gauges of economic activity overstate standard of living, say researchers

Rib-X Pharmaceuticals co-founder discovers new ribosomal structures of antibiotics

MDS intends to make Substantial Issuer Bid

LifePoint Hospitals reports fourth-quarter and full-year 2009 financial results

University of Missouri researchers visualize "terminals" inside proline degrading enzyme

Nuvo Research reports net income in fourth-quarter, driven by FDA approval of Pennsaid

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News